Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSunrise Resources PLC Regulatory News (SRES)

Share Price Information for Sunrise Resources PLC (SRES)

Share Price is delayed by 15 minutes
Get Live Data
0.023    0.00 (0.00%)
Bid:
0.021
Ask:
0.025
Spread: 0.004 (19.048%)
Market Cap: £2.16m
SRES Live PriceLast checked at - London Stock Exchange

Intraday Sunrise Resources PLC Share Chart

Update: CS Pozzolan- Perlite Project

17 Aug 2021 07:00

RNS Number : 8150I
Sunrise Resources Plc
17 August 2021
 

17 August 2021

 

Sunrise Resources plc ("Sunrise" or "the Company")

Update: CS Pozzolan- Perlite Project

Sunrise Resources plc is pleased to announce positive test results from recent commercial concrete pours using natural pozzolan from the Company's CS Pozzolan-Perlite Deposit in Nevada, USA, and to provide a general update on perlite customer trials.

 

Highlights:

 

Natural Pozzolan

 

· Two commercial concrete pours carried out by large Cement & Ready- Mix Company ("CRMC") as due diligence towards commercial agreement.

 

· Positive results reported:

 

· Preliminary results show early strength gain in excess of target strengths.

 

· Seven-day concrete strengths exceed the 24-day target strengths after just 7 days curing.

 

Perlite

 

· All customer trials for expansion of Horticultural Grade Perlite now completed for 100-ton bulk sample.

 

· All trial results now received.

 

· Most recent customer trial considered very successful.

 

 

 

Commenting today, Executive Chairman Patrick Cheetham said: "We are delighted to be announcing these exciting results which come after a number of frustrating delays. The preliminary results from the concrete pours using CS natural pozzolan are first-rate and, we anticipate, will provide the basis for a more structured arrangement with the CRMC carrying out this work."

"Interest in using the CS natural pozzolan in concrete continues to grow and a number of additional companies have requested samples in recent weeks, no doubt driven by the bleak long-term outlook for coal fly ash supplies in the USA."

"Looking to the future, we believe that the US$1.2 trillion infrastructure spending stimulus recently passed by the US Senate and embraced by President Joe Biden, together with Biden's climate plan will give further impetus to pozzolan demand and so we are looking at possibilities to grow our business by acquiring additional pozzolan deposits favourably located for other regional centres of concrete demand in the western United States."

"Whilst development of the perlite for uses other than for natural pozzolan is the smaller of the two business opportunities at the CS Project, we are pleased to have received great feedback from the most recent customer trials of our horticultural grade raw perlite and look forward to advancing this and other production options in tandem with the production of natural pozzolan."

 

Further information:

 

Sunrise Resources plc

Patrick Cheetham, Executive Chairman

Tel: +44 (0)1625 838 884

 

Beaumont Cornish Limited

Nominated Adviser

James Biddle/Roland Cornish

Tel: +44 (0)207 628 3396

 

Peterhouse Capital Limited

Broker

Lucy Williams/Duncan Vasey

 

Tel: +44 (0)207 469 0930

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

Shares in the Company trade on AIM. EPIC: "SRES". Website: www.sunriseresourcesplc.com

 

Detailed Information

The Company's CS Project is located near Tonopah in Esmeralda County, Nevada and contains large deposits of mine-ready natural pozzolan, along with deposits of perlite.

In December 2020, a 500-ton bulk sample of pozzolan was delivered to a large CRMC1 for commercial scale test grinding and trials in some commercial concrete pours.

This work programme has experienced a number of delays, but in May 2021 the Company announced that a test grind had been successfully completed. The Company has now received preliminary results from two commercial concrete pours made using the ground pozzolan in partial substitution for Portland cement.

Concrete mixes are tailored to achieve target strengths appropriate to the demands placed on the structures being manufactured and a target strength is set at a specified number of days after pouring.

In the case of the two concrete pours now being reported the specified (target) strength was 3,000 psi at 28 days. In both cases the concrete exceeded this target strength after just 7 days curing.

After 7 days curing, the concrete made using CS natural pozzolan achieved 105% and 113% of the target strengths respectively in the two tests. This is an excellent result as the often specified seven-day target commonly corresponds to approximately 70 percent of the target compressive strengths.

 

Perlite Customer Trials

In the Company's announcement of 23 February 2021, the Company advised that results were still awaited from certain customer trials of the horticultural grade raw perlite ore samples produced from its 100-ton bulk sample and that due to the high market demand and fully utilised furnace capacity another potential customer had not yet started its trial. The Company also advised that it had a 200-ton sample of perlite on hand ready for further processing to provide additional graded ore samples when necessary.

All planned trials on the raw perlite produced from the 100-ton sample have now been completed and results received. The Company had previously advised that results then available were inconclusive. However, in the last expansion trial to be completed, the potential customer advised that they were able to produce expanded horticultural perlite at very low target densities with good production rates and a good-looking product. They also advise that, assuming the previously reported sizing issues were resolved as expected, the CS raw perlite would be a premium product, very good for the US market and that they would be happy to start receiving a regular supply.

The Company has been waiting on the results of all trials before committing to process the 200-ton bulk sample and so this work can now be scheduled.

 

Notes:

1. The CRMC is an internationally recognised Company and has a substantial ready-mix concrete business that is a captive customer for its cement products, and which could also use CS natural pozzolan as a replacement for the large volumes of fly ash it has traditionally used in its concrete business.

 

2. "Curing" is a chemical process that takes place within concrete whereby water and cement react chemically to produce calcium-silica-hydrate (C-S-H), the important compound that binds the concrete sand and aggregate fillers together. Curing plays an important role on strength development and durability of concrete and takes place immediately after concrete placing and finishing and continues for many months and even years. In Portland-cement-based concretes, C-S-H forms quickly but an unwanted by-product, Calcium Hydroxide (CH), also forms at the expense of C-S-H. Formation of CH can weaken the concrete and compromise density and allows ingress of water contaminated with sulphates and chlorides that can attack the concrete and any reinforcing steel. When pozzolan is used in concrete the pozzolan reacts with and converts deleterious CH into additional C-S-H. increasing density and strengthening the concrete further.

 

3. The news release may contain certain statements and expressions of belief, expectation or opinion which are forward looking statements, and which relate, inter alia, to the Company's proposed strategy, plans and objectives or to the expectations or intentions of the Company's directors. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Company to be materially different from such forward-looking statements. Accordingly, you should not rely on any forward-looking statements and save as required by the AIM Rules for Companies or by law, the Company does not accept any obligation to disseminate any updates or revisions to such forward-looking statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFSDTSIRLIL
Date   Source Headline
6th May 20267:00 amRNSISSUE OF WARRANTS
30th Apr 20264:28 pmRNSTotal Voting Rights
23rd Apr 20263:08 pmRNSResult of WRAP Retail Offer
21st Apr 20264:00 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSWRAP Retail Offer for up to £50,000
20th Apr 20263:43 pmRNSHolding(s) in Company
17th Apr 20264:40 pmRNSHolding(s) in Company
17th Apr 20264:07 pmRNSHolding(s) in Company
17th Apr 202612:00 pmRNSHolding(s) in Company
13th Apr 202612:15 pmRNSPlacing and Issue of Equity
26th Mar 202611:16 amRNSVoting at AGM
25th Mar 202610:46 amRNSResult of AGM
23rd Mar 20261:50 pmRNSDIRECTORS’ DEALING
27th Feb 20267:00 amRNSANNUAL REPORT TO 30 SEPTEMBER 2025 & NOTICE OF AGM
20th Feb 202612:30 pmRNSAudited Results for the year to 30 September 2025
4th Feb 20265:56 pmRNSHolding(s) in Company
9th Jan 20269:48 amRNSUPDATE ON HAZEN PROJECT, NEVADA, USA
8th Jan 20267:00 amRNSPIOCHE SEPIOLITE PROJECT, NEVADA, USA
8th Dec 20257:00 amRNSHAZEN PROJECT, NEVADA, USA
3rd Nov 202510:50 amRNS-RGarfield Royalty Interest
31st Oct 20257:00 amRNSPioche Sepiolite Project - Update
28th Oct 20257:00 amRNSNominated Broker
1st Oct 20259:54 amRNSHolding(s) in Company
30th Sep 20252:43 pmRNSTotal Voting Rights
24th Sep 20253:00 pmRNSIssue of Shares following Conversion & TVR
16th Sep 202510:16 amRNSHolding(s) in Company
15th Sep 202510:31 amRNSCS NATURAL POZZOLAN PROJECT UPDATE
15th Sep 20259:28 amRNSHAZEN PROJECT UPDATE
7th Aug 202512:17 pmRNSHolding(s) in Company
1st Aug 20252:00 pmRNSResult of WRAP Retail Offer
31st Jul 20257:01 amRNSWRAP Retail Offer launches
31st Jul 20257:00 amRNSPlacing raised £200k, launch of WRAP retail offer
23rd Jul 20257:00 amRNSPioche Sepiolite Project - Update
21st Jul 20257:00 amRNSSale Option Agreement – Hazen Project
14th Jul 20253:25 pmRNSHolding(s) in Company
9th Jun 20257:00 amRNSConvertible Security – Extension of Term
3rd Jun 20252:03 pmRNS-RGarfield Royalty Interest
21st May 20257:00 amRNSHALF-YEARLY REPORT 2025
15th Apr 202512:00 pmRNSPioche Sepiolite Project – Positive Test Results
9th Apr 20257:00 amRNS-RGold & Silver Projects
2nd Apr 202512:00 pmRNS-RPioche Sepiolite Project
31st Mar 202510:32 amRNSDirectorate Change
31st Mar 20258:49 amRNSTotal Voting Rights
14th Mar 20254:44 pmRNSVoting at AGM
13th Mar 202511:50 amRNSResult of AGM
12th Mar 202512:07 pmRNSDIRECTORS’ DEALINGS, ISSUE OF EQUITY & TVR
10th Mar 202512:00 pmRNSAppointment of Non-Executive Director
28th Feb 20251:29 pmRNSTotal Voting Rights
17th Feb 20255:16 pmRNSIssue of Shares following Conversion & TVR
14th Feb 202511:00 amRNSANNUAL REPORT & NOTICE OF 2025 AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.